Months after an advisory panel backed easing limits on BPC-157 and others, Medical Daily reviews hospitalizations and Nevada fines over two intubated women.
Recap by typeshit. Full story at Medical Daily.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Nippard rates the two drugs highly for supervised weight loss and notes that many popular peptide claims lack strong human evidence.
A short social post on whether appetite from cannabis changes when someone is on a GLP-1 medication. There is no detail or source behind it.
Loading…